UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.12B |
| 2 |
Apple
AAPL
|
+$1.08B |
| 3 |
Microsoft
MSFT
|
+$1.05B |
| 4 |
Nike
NKE
|
+$1.03B |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$821M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BioMarin Pharmaceuticals
BMRN
|
+$389M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$383M |
| 3 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$348M |
| 4 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$263M |
| 5 |
NRG Energy
NRG
|
+$237M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.8% |
| 2 | Financials | 8.25% |
| 3 | Healthcare | 6.4% |
| 4 | Consumer Discretionary | 5.85% |
| 5 | Communication Services | 4.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
701
Pultegroup
PHM
$24.7B
| $90.1M | 0.02% |
818,458
+19,316
| +2% | +$2.19M |
|
702
PUT
KraneShares CSI China Internet ETF
KWEB
$5.66B
| $89.8M | 0.02% |
3,325,100
+577,300
| +21% | +$16.5M |
|
703
CALL
Pfizer
PFE
$142B
| $89.8M | 0.02% |
3,208,832
+410,298
| +15% | +$11.3M |
|
704
PUT
Applied Materials
AMAT
$428B
| $89.5M | 0.02% |
379,100
-162,600
| -30% | -$34.9M |
|
705
CALL
Qualcomm
QCOM
$167B
| $89.2M | 0.02% |
447,620
-5,556
| -1% | -$1.05M |
|
706
ZTO Express
ZTO
$18.2B
| $89.1M | 0.02% |
4,292,185
+403,811
| +10% | +$8.83M |
|
707
Equity Residential
EQR
$25.2B
| $88.8M | 0.02% |
1,280,061
-175,350
| -12% | -$11.4M |
|
708
CALL
Occidental Petroleum
OXY
$54.4B
| $88.2M | 0.02% |
1,399,648
+110,798
| +9% | +$7.11M |
|
709
CALL
Johnson & Johnson
JNJ
$609B
| $88.2M | 0.02% |
603,495
+98,100
| +19% | +$14.6M |
|
710
MSCI
MSCI
$42.2B
| $88.1M | 0.02% |
182,854
+16,170
| +10% | +$8.02M |
|
711
Vulcan Materials
VMC
$36.7B
| $88M | 0.02% |
354,006
+3,520
| +1% | +$910K |
|
712
ASE Group
ASX
$83.2B
| $87.7M | 0.02% |
7,678,222
-422,994
| -5% | -$4.59M |
|
713
CALL
MP Materials
MP
$8.17B
| $87.5M | 0.02% |
6,876,080
| – | – |
|
714
CALL
Boeing
BA
$186B
| $87.5M | 0.02% |
480,693
+276,636
| +136% | +$49.3M |
|
715
Packaging Corp of America
PKG
$22.3B
| $87.4M | 0.02% |
478,997
+116,024
| +32% | +$21.1M |
|
716
Xcel Energy
XEL
$48B
| $87.2M | 0.02% |
1,632,353
-215,421
| -12% | -$11.7M |
|
717
iShares US Medical Devices ETF
IHI
$3.34B
| $86.6M | 0.02% |
1,546,160
+280,267
| +22% | +$15.7M |
|
718
CALL
Procter & Gamble
PG
$340B
| $86.4M | 0.02% |
524,182
+115,105
| +28% | +$18.8M |
|
719
Centene
CNC
$31.5B
| $85.4M | 0.02% |
1,288,009
-88,936
| -6% | -$6.47M |
|
720
Ferguson
FERG
$49B
| $85.2M | 0.02% |
439,945
-114,228
| -21% | -$24M |
|
721
CALL
Coca-Cola
KO
$370B
| $85.1M | 0.02% |
1,336,889
-247,608
| -16% | -$15.3M |
|
722
Infosys
INFY
$49.5B
| $84.9M | 0.02% |
4,561,704
-918,892
| -17% | -$16M |
|
723
First Trust Managed Municipal ETF
FMB
$2.06B
| $84.7M | 0.02% |
1,658,996
+43,424
| +3% | +$2.22M |
|
724
Delta Air Lines
DAL
$60.8B
| $84.7M | 0.02% |
1,784,823
+87,794
| +5% | +$4.37M |
|
725
CALL
State Street SPDR S&P Biotech ETF
XBI
$9.74B
| $84.4M | 0.02% |
910,000
+103,800
| +13% | +$9.31M |
|
Similar funds
UBS Group's Q2 2024 Portfolio in Review
As of Q2 2024, UBS Group held 10,501 positions worth $405B, up 0.81% from $402B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
UBS Group's Q2 2024 filing shows 1,227 new, 3,693 increased, 4,131 reduced and 1,043 closed positions. Its largest new stake was SLB Ltd: 10,925,731 shares worth $515M. The largest sale was BioMarin Pharmaceuticals, an estimated $389M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.
- UBS Group's largest Q2 2024 buy was SLB Ltd: 10,925,731 shares worth $515M.
- UBS Group added most to NVIDIA in Q2 2024, an estimated $1.12B increase.
- UBS Group's biggest Q2 2024 reduction was BioMarin Pharmaceuticals, cutting an estimated $389M.
- UBS Group fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $263M.
- UBS Group's ten largest holdings make up 18% of its $405B portfolio in Q2 2024.
- UBS Group opened 1,227 new positions and closed 1,043 in Q2 2024.
- UBS Group's portfolio value rose 0.81% quarter-over-quarter to $405B.
Based on UBS Group's 13F filing for Q2 2024, filed 14 Aug 2024.